1 / 31

CELL WALL SYNTHESIS INHIBITORS

CELL WALL SYNTHESIS INHIBITORS . CELL WALL SYN. INHIBITORS. BETA LACTAM ANTI BIOTICS PENCILLINS CEPHALOSPORINS CARBAPENEMS MONOBACTAMS. Beta- Lactam Antibiotics. Beta- Lactam Antibiotics. Strep throat IM, syphilis. Skin infections fm staph/strep. Bacterial URI.

dani
Télécharger la présentation

CELL WALL SYNTHESIS INHIBITORS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CELL WALL SYNTHESIS INHIBITORS

  2. CELL WALL SYN. INHIBITORS • BETA LACTAM ANTI BIOTICS • PENCILLINS • CEPHALOSPORINS • CARBAPENEMS • MONOBACTAMS

  3. Beta- Lactam Antibiotics

  4. Beta- Lactam Antibiotics Strep throat IM, syphilis Skin infections fm staph/strep Bacterial URI SE: Hypersensitivity is primary problem. Pruritic rash. Anaphylaxis also occurs.

  5. Penicillins • Bactericidal • Peptidoglycan cell wall organisms • Not effective against Mycobacterium, Protozoa , Fungi & viruses.

  6. Interfere with last step of bacterial synthesis—trans peptidation • Results in exposure of less stable membrane. • Cell lysis occurs through osmotic pressure or activation of autolysins • Thus they are bactericidal.

  7. Penicillin binding proteins • Penicillins inactivate many proteins on the bacterial cell membrane. These pbps are bacterial enzymes involved in the synthesis of the cell wall • Inhibition of trans peptidase • Production of autolysins

  8. Antistaphylococcal penicillins • All are stable to penicillinase • Cloxacillin • Dicloxacillin • Methicillin • Nafcillin • Oxacillin

  9. Antipseudomonal penicillins • Particularly active against P. aeruginosa • Azlocillin • Carbenicillin • Mezlocillin • Piperacillin • Ticarcillin

  10. Clinical use of penicillin G. • Pneumococcal pneumonia • Syphilis single treatment with penicillin is curative. No resistance has been reported • gonorrhea

  11. ROUTES : • PENCILLIN V , AMOXICILLIN + CLAVULANIC ACID ORAL • DEPOT : PROCAINE PENCILLIN G, BENZATHINE PENCILLIN G • DO NOT CROSS BBB UNLESS INFLAMED • EXCRETION : TUBULAR SECRETION

  12. SE • HYPERSENSITIVITY—the metabolite penicilloic acid serves as a hapten to cause immune reaction. • Maculopapular rash—ampicillin • Angioedema • anaphylaxis

  13. DIARRHEA– disruption of the normal balance of intestinal micro organisms. Pseudo membranous colitis may also occur. • NEPHRITIS ( Mostly Methicillin) • NEUROTOXICITY– care in epileptics • CATION TOXICITY • Platelet dysfunction ( Carbenicillin & Ticarcillin

  14. Resistance • Beta lactamase enzyme hydrolyzes the cyclic bond of the beta lactam ring—results in loss of bactericidal activity. • Decreased penetration of the antibiotic through the outer cell membrane prevents the drug from reaching the target pbp.

  15. Beta- Lactam Antibiotics Commonly used, some resistance, lower cost Also commonly used, less resistance, higher cost $ $ $ $ Expensive $ $ $ $ Resistant/ Severe Infections SE: all have some degree of cross reactivity w/pen allergic pt. 5-15%

  16. 1st Generation • Cefazolin • Cephalexin • Cefadroxil • Cephradine • Broad spectrum, mostly oral, commonly used, some resistance, lower cost, • Active against - Proteus, E. coli, K. pneumonia (PEcK)

  17. 2nd Generation • Cefamandole • Cefoxitin • Cefaclor • Cefotetan • Cefuroxime • Less resistance, higher cost, oral/IM/IV. • H. influenza, Enterobacter, Neisseria + 1st (HEN PEcK)

  18. 3rd Generation • Cefoperazone • Ceftriaxone • Cefixime • Cefotaxime • Ceftazidime • Expensive, for resistant/severe infections, Septic shock, MENINGITIS.

  19. 4th Generation • Cefepime • Newer agent • Very broad spectrum activity

  20. Common usage • Cephalexin - Pharyngitis • Cefazolin - Bone penetration • Cefoxitin – Anaerobes ( Bacteroides fragilis) abdominal sepsis and PID • Ceftazidime – most active against P. aeruginosa • Ceftriaxone – good bone penetration, Neisseria

  21. DISTRIBUTION • BBB: ONLY 3rd GENERATION • MENINGITIS : CEFTRIAXONE, CEFOTAXIME • EXCRETION : RENAL SECRETION (Ceftriaxone, Cefoperazone excreted mostly through bile)

  22. Cephalosporins are mostly not effective against • MRSA, • Listeria monocytogenes • Clostridium difficile • Enterococci. • Newer agent classified as 4th generation (Cefepime) has shown some effectiveness

  23. SE • HYPERSENSITIVITY • CEFOPERAZONE, CEFAMANDOLE – CI IN ALCOHOL • BLEEDING

  24. Beta- Lactam Antibiotics Nephrotoxic Nephrotoxic & Ototoxic

  25. CARBAPENEMS Eg; Imipenem/Cilastatin Cilastatin is not a antibiotic , it’s a peptidase inhibitor that protects imipenem from degradation. Broad spectrum, Mostly IV route and excreted by glomerular filtration. SE: Diarrhea, seizures if increased plasma levels.

  26. Carbapenems • Empiric therapy – active against G positive and negative • Eosinophilia , neutropenia

  27. MONOBACTAMS • Eg; Aztreonam Only in this class. Narrow spectrum – enterobacteria. IV & IM routes , excreted through urine. Relatively non toxic, but can cause skin rash, phlebitis.

  28. Vancomycin • Inhibits synthesis of bacterial cell wall phospholipids and Peptidoglycan • Reserved for serious infections with gram +ve • Used mainly for Methicillin resistant Staphylococcus aureus (MRSA) and Methicillin resistant Staphylococcus epidermidis (MRSE) • And also for antibiotic associated Colitis due to Clostridium difficile or Staphylococci

  29. Slow IV route preferred, • Excretion – glomerular filtration • SE: fever, chills , phlebitis at the site of the injection • Shock reported with fast rapid administration along with Flushing due to histamine release. ( RED MAN SYNDROME)

  30. BETA LACTAMASE INHIBITORS • CLAVULANIC ACID • SULBACTAM • TAZOBACTAM • NO ANTI BACTERIAL ACTIVITY

More Related